| Citation: |
HE Yang, YANG Runfeng, ZHOU Yingying, XU Qian, YAN Hao, JIANG Lei, JIANG Xiaohui, HUANG Yi. Effect of Aprepitant on Chemotherapy-induced Adverse Reactions in Gynecological Malignancy Patients[J]. Cancer Research on Prevention and Treatment, 2018, 45(11): 913-916. DOI: 10.3971/j.issn.1000-8578.2018.18.0265
|
To observe the curative effect of aprepitant on chemotherapy-induced nausea and vomiting(CINV) and hemoglobin level in gynecological malignancy patients.
A total of 85 gynecological malignancy patients in our hospital from July 2013 to June 2017 were divided into the aprepitant group and the control group, according to patients' anti-nausea drug usage.Both groups received chemotherapy and conventional symptomatic treatment; the aprepitant group was added with aprepitant.We observed nausea and vomiting, hemoglobin level and peripheral blood in two groups.
The incidence of nausea and vomiting after chemotherapy was lower in the aprepitant group(P < 0.05), but there was no significant difference in the incidence of dizziness, headache or other adverse reactions between two groups (P > 0.05).The decrease of erythrocyte number after chemotherapy in the aprepitant group was slightly less than that in the control group(P > 0.05).
The aprepitant could not only effectively prevent the occurrence of chemotherapy-induced nausea and vomiting, improve patients' quality of life and treatment compliance, but also make patients eat early, which is conducive tothe formation of hemoglobin and reducing tumor burden and chemotherapy-induced anemia.
| [1] |
Ruhlmann CH, Herrstedt J.Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting[J].Expert Opin Drug Saf, 2011, 10(3):449-62. doi: 10.1517/14740338.2011.563235
|
| [2] |
Rapoport BL.Efficacy of a triple antiemetic regimen with aprepitant for the prevention of chemotherapy-induced nausea and vomiting:effects of gender, age, and region[J].Curr Med Res Opin, 2014, 30(9):1875-81. doi: 10.1185/03007995.2014.925866
|
| [3] |
高艳, 许崇安, 刘殊, 等.癌性贫血对恶性肿瘤患者生活质量及生存期的影响[J].中华肿瘤防治杂志, 2009, 16(24):1957-60. http://d.old.wanfangdata.com.cn/Thesis/Y1299956
Gao Y, Xu CA, Liu S, et al.Influence of malignant tumor anemia on the malignancy patients' quality of life and survival[J].Zhonghua Zhong Liu Fang Zhi Za Zhi, 2009, 16(24):1957-60. http://d.old.wanfangdata.com.cn/Thesis/Y1299956
|
| [4] |
de U Vries, Reif K, Petermann F.Tumorbedingte Fatigue und ihre psychosozialen Belastungen[J].Der Urol, 2012, 51(3):413-21. doi: 10.1007/s00120-012-2844-3
|
| [5] |
Hamada S, Hinotsu S, Kawai K, et al.Antiemetic efficacy and safety of a combination of palonosetron, aprepitant, and dexamethasone in patients with testicular germ cell tumor receiving 5-day cisplatin-based combination chemotherapy[J].Support Care Cancer, 2014, 22(8):2161-6. doi: 10.1007/s00520-014-2182-7
|
| [6] |
葛鲁倩, 孙文洲, 赵欣瑶, 等.新辅助化疗联合间隔肿瘤细胞减灭术对晚期卵巢癌耐药性和生存时间的影响及耐药性影响因素分析[J].实用妇产科杂志, 2017, 33(1):43-7. http://d.old.wanfangdata.com.cn/Periodical/syfckzz201701016
Ge LQ, Sun WZ, Zhao XY, et al.Effect of neoadjuvant chemotherapy combined with interval of tumor cells to destroy the loss(NACT-IDS) on drug resistance and survival time of advanced ovarian cancer and analysis of drug resistance[J].Shi Yong Fu Chan Ke Za Zhi, 2017, 33(1):43-7. http://d.old.wanfangdata.com.cn/Periodical/syfckzz201701016
|
| [7] |
陈怡雯, 倪丽萍.1例阿瑞匹坦用于化疗后Ⅲ级呕吐的观察与护理[J].齐齐哈尔医学院学报, 2014, 35(22):3429-30. http://d.old.wanfangdata.com.cn/Periodical/qqhryxyxb201422091
Chen YW, Ni LP.One case of his minions horse temple used to grade Ⅲ vomiting after chemotherapy of observation and nursing care[J].Qiqihaer Yi Xue Yuan Xue Bao, 2014, 35(22):3429-30. http://d.old.wanfangdata.com.cn/Periodical/qqhryxyxb201422091
|
| [8] |
裴丽, 罗艳, 黄显金, 等.阿瑞匹坦的用药风险与合理应用[J].中国药物应用与监测, 2015, 12(5):310-2. http://d.old.wanfangdata.com.cn/Periodical/zgywyyyjc201505015
Pei L, Luo Y, Huang XJ, et al.Risk and rational use of aripitant[J].Zhongguo Yao Wu Ying Yong Yu Jian Ce, 2015, 12(5):310-2. http://d.old.wanfangdata.com.cn/Periodical/zgywyyyjc201505015
|
| [9] |
董爽, 王俊, 胡胜, 等.女性肺癌和乳腺癌患者中阿瑞匹坦与奥氮平预防多日化疗所致延迟性恶心呕吐的疗效观察[J].肿瘤防治研究, 2017, 44(5):356-9. doi: 10.3971/j.issn.1000-8578.2017.05.009
Dong S, Wang J, Hu S, et al.Aprepitant versus Olanzapine for Prevention of Nausea and Vomiting Induced by Multiday Chemotherapy in Female Lung Cancer or Breast Cancer Patients[J].Zhong Liu Fang Zhi Yan Jiu, 2017, 44(5):356-9. doi: 10.3971/j.issn.1000-8578.2017.05.009
|
| [10] |
Chawla SP, Grunberg SM, Gralla RJ, et al.Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting[J].Cancer, 2003, 97(9):2290-300. doi: 10.1002/(ISSN)1097-0142
|
| [11] |
陈文艳, 熊建萍.肿瘤缺氧及其靶向治疗研究进展[J].国际肿瘤学杂志, 2006, 33(1):8-11. doi: 10.3760/cma.j.issn.1673-422X.2006.01.004
Chen WY, Xiong JP.Advances in tumor hypoxia and its targeted therapy[J].Guo Ji Zhong Liu Xue Za Zhi, 2006, 33(1):8-11. doi: 10.3760/cma.j.issn.1673-422X.2006.01.004
|
| [12] |
韩金凤, 王芳.癌性贫血的研究进展[J].辽宁中医药大学学报, 2009, 11(10):198-9. http://d.old.wanfangdata.com.cn/Periodical/lchc200621044
Han JF, Wang F.Advances in research on carcinogenic anemia[J].Liaoning Zhong Yi Yao Da Xue Xue Bao, 2009, 11(10):198-9. http://d.old.wanfangdata.com.cn/Periodical/lchc200621044
|
| [13] |
许崇安, 李琳, 高艳, 等.癌性贫血对肺癌患者生活质量及预后的影响[J].中华肿瘤防治杂志, 2010, 17(10):763-6. doi: 10.1111-j.1365-2621.2010.02514.x/
Xu CA, Li L, Gao Y, et al.Impact of malignant tumor anemia on quality of life and prognosis in patients with lung cancer[J].Zhonghua Zhong Liu Fang Zhi Za Zhi, 2010, 17(10):763-6. doi: 10.1111-j.1365-2621.2010.02514.x/
|
| [14] |
陈洪琴, 周容.妊娠期与产褥期贫血临床处理[J].实用妇产科杂志, 2016, 32(9):645-7. http://d.old.wanfangdata.com.cn/Periodical/syfckzz201609003
Chen HQ, Zhou R.Clinical treatment of gestational and puerperal anemia[J].Shi Yong Fu Chan Ke Za Zhi, 2016, 32(9):645-7. http://d.old.wanfangdata.com.cn/Periodical/syfckzz201609003
|
| [15] |
Shah N, Andrews J, Goodnough LT.Transfusions for anemia in adult and pediatric patients with malignancies[J].Blood Rev, 2015, 29(5):291-9. doi: 10.1016/j.blre.2015.02.001
|
| [1] | JIN Guanghao, GU Ke. Advances in Bone Marrow Function Protection for Cervical Cancer Intensity-Modulated Radiotherapy Informed by Magnetic Resonance Imaging[J]. Cancer Research on Prevention and Treatment, 2025, 52(9): 792-797. DOI: 10.3971/j.issn.1000-8578.2025.25.0182 |
| [2] | ZHENG Jianqing, LI Tingting, XIAO Lihua, HUANG Bifen, WU Min. Value of Magnetic Resonance Imaging in Diagnosis of Pelvic Lateral Lymph Node Metastasis in Rectal Cancer:A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2020, 47(1): 52-57. DOI: 10.3971/j.issn.1000-8578.2020.19.0706 |
| [3] | WANG Chengsheng, XUE Yunqing, HUANG Xinming, DUAN Qing. Imaging Features of Primary Hemangiopericytoma of Bone[J]. Cancer Research on Prevention and Treatment, 2017, 44(4): 276-280. DOI: 10.3971/j.issn.1000-8578.2017.04.008 |
| [4] | LI Haiyuan, HUA Chenzhao, ZHOU Fenghai. Research Progress of Novel Endoscopic Imaging Technology for Bladder Cancer Diagnosis[J]. Cancer Research on Prevention and Treatment, 2016, 43(5): 418-421. DOI: 10.3971/j.issn.1000-8578.2016.05.021 |
| [5] | WANG Shu, NI Qing. Accuracy of Mammography, Color Doppler Ultrasonography and Magnetic Resonance Imaging in Predicting Ductal Carcinoma in Situ[J]. Cancer Research on Prevention and Treatment, 2015, 42(06): 597-600. DOI: 10.3971/j.issn.1000-8578.2015.06.014 |
| [6] | Cao Changqi, Li Shijie, Li Ziyu, Zhang Jichang, Wu Qi. Application of Narrow Band Imaging in Diagnosis for Multiple Primary Cancer of Upper Gastrointestinal Tract[J]. Cancer Research on Prevention and Treatment, 2012, 39(08): 997-1000. DOI: 10.3971/j.issn.1000-8578.2012.08.028 |
| [7] | XU Li-ying, KONG Xiang-quan, XU Hai-bo, LIU Ding-xi, YU Qun, XIONG Yin. The Diagnosis of Dynamic Enhanced Magnetic Resonance Imaging in Early Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2004, 31(10): 617-618. DOI: 10.3971/j.issn.1000-8578.2565 |
| [8] | XU Li-ying, KONG Xiang-quan, XU Hai-bo, LIU Ding-xi, YU Qun, ZENG Jun. The Diagnostic Value of Dynamic Enhanced MR Imaging for Special Types of Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2004, 31(10): 611-613. DOI: 10.3971/j.issn.1000-8578.2567 |
| [9] | GUAN Chang-qun, LI Ai-juan, YANG Ben-qiang, LIU Mei. Proton MR Spectroscopy and MRI Diagnosis in Brain Gliomas (Report of 20 cases)[J]. Cancer Research on Prevention and Treatment, 2004, 31(09): 559-560. DOI: 10.3971/j.issn.1000-8578.3152 |
| [10] | GUAN Chang qun, LI Ai juan, ZHOU Li juan, et al. Diagnosis of multiforme glioblastoma using CT and MRI (Report of 21 cases)[J]. Cancer Research on Prevention and Treatment, 2003, 30(01): 65-66. DOI: 10.3971/j.issn.1000-8578.76 |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: